Scinai Immunotherapeutics announces private placement raising USD 4 million
Bitget2026/10/14 12:03- Scinai Immunotherapeutics priced a private placement with a life sciences institutional investor, targeting gross proceeds of about $4 million.
- Deal includes 2,458,334 ADSs or pre-funded warrants, sold with Series A-1 warrants at a combined price of $1.20 per ADS.
- Series A-1 warrants cover up to 3,687,501 ADSs, carry a $1.20 exercise price, are exercisable immediately, expire in five years.
- Separate warrant inducement covers cash exercise of April 2026 warrants for 879,194 ADSs at a reduced $1.20 exercise price.
- Investor to receive new unregistered Series A-1 warrants for 1,318,791 ADSs; closing expected around Oct. 15, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic spends $3.4 billion to purchase gas-fired power equipment to supply electricity for data centers
In September, Anthropic directly acquired Caterpillar equipment orders worth 3.4 billion USD, securing 1.7 GW of gas generator units, marking the largest single purchase of power generation equipment in AI history. This move bypassed utility middlemen, capturing scarce capacity at prices set years ago with near-term delivery. It is part of Anthropic's plan to invest over 895 billion USD in computing infrastructure by 2045.
Why Nintendo Stock Is One to Watch Ahead of the Holiday Season
A wallet address sold 1.44 million TRX via SunSwap in exchange for 460,000 USDT.
Data: Whales have cumulatively withdrawn approximately 13.4 million USDT from a certain exchange.
Crypto prices
More
